Compared to other hypoglycemic GLP-1 analogs, injectable liraglutide marketed by Novo Nordisk has reiterated its position as an efficient and safe post prandial glycemic level controller. Here is the study.

Team@CMHF

Read the rest of this entry »

Antidiabetic drug Liraglutide, reduces meal-related hyperglycemia (for 12 hours after administration) by increasing insulin secretion, delaying gastric emptying, and suppressing prandial glucagon secretion. But its safety is questionable since it is associated with pancreatitis, and increased calcitonin secretion associated with thyroid tumour in mice. Read on to know more.

Team@CMHF

Read the rest of this entry »

Busy schedule through the day keeps most of us away from exercising on a routine basis. ACSM has brought out a new book with guidelines for adults. Here are the salient points of this book .If you haven’t been exercising read on and get motivated.

Team@CMHF

Read the rest of this entry »

Inappropriate sexual behavior (ISB) is an important topic in geriatrics; etiologies remain unclear and evidence for the efficacy of treatment strategies is limited

The aims of this study were to provide a description of the phenomenology of ISB in the geriatric population, to identify potential contributing factors, and to review the efficacy of interventions aimed at reducing ISB.

Read the rest of this entry »

An injury patient is to be analyzed not only by the computer test but by general interpretation. Read on to know more.

Team@CMHF

Read the rest of this entry »